Table 2. Clinical data and outcomes in each TACE procedures between TRA-TACE group and TFA-TACE group.
| Characteristics | Overall (n=323) | r-TACE (n=160) | f-TACE (n=163) | P value |
|---|---|---|---|---|
| Child-Pugh classification, n (%) | 0.254 | |||
| Class A | 272 (84.2) | 131 (81.9) | 141 (86.5) | |
| Class B | 51 (15.8) | 29 (18.1) | 22 (13.5) | |
| INR value, n (%) | 0.453 | |||
| ≥1.5 | 19 (5.9) | 11 (6.9) | 8 (4.9) | |
| <1.5 | 304 (94.1) | 149 (93.1) | 155 (95.1) | |
| PT value, n (%) | 0.922 | |||
| >15 s | 43 (13.3) | 21 (13.1) | 22 (13.5) | |
| ≤15 s | 280 (86.7) | 139 (86.9) | 141 (86.5) | |
| Tumor broaden, n (%) | 0.636 | |||
| Simple | 119 (36.8) | 61 (38.1) | 58 (35.6) | |
| Multiple | 204 (63.2) | 99 (61.9) | 105 (64.4) | |
| Tumor location | 0.155 | |||
| Left | 49 (15.2) | 19 (11.9) | 30 (18.4) | |
| Right | 157 (48.6) | 85 (53.1) | 72 (44.2) | |
| Bilateral | 117 (36.2) | 56 (35.0) | 61 (37.4) | |
| Technical success, n (%) | 0.102 | |||
| Success | 313 (96.9) | 152 (95.0) | 161 (98.8) | |
| Failure | 10 (3.1) | 8 (5.0) | 2 (1.2) | |
| Puncture failure | 5 (3.1) | – | ||
| Cannulation failure | 3 (1.9) | 2 (1.2) | ||
| Access site-related complications, n (%) | 0.083 | |||
| No | 311 (96.3) | 157 (98.1) | 154 (94.5) | |
| Yes | 12 (3.7) | 3 (1.9) | 9 (5.5) | |
| Vascular complications | – | – | – | |
| RAO | – | 3 (1.9) | – | |
| Bleeding complications | 0.003* | |||
| Minor | – | – | 6 (3.7) | |
| Major | – | – | 3 (1.8) | |
| Postoperative dysuresia, n (%) | 0.030* | |||
| Yes | 6 (1.9) | – | 6 (3.7) | |
| No | 317 (98.1) | 160 (100.0) | 157 (96.3) |
TRA, transradial access; TFA, transfemoral access; TACE, transarterial chemoembolization; INR, international normalized ratio; PT, prothrombin time; RAO, radial artery occlusion; PA, pseudoaneurysm. *, P<0.05.